Yang Liu

发表

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection

R. Gale, Junnian Zheng, Xi Zhang, 2020, Leukemia.

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma.

Junnian Zheng, K. Qi, Kailin Xu, 2021, Transplantation and cellular therapy.

CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia

P. Zhou, Kailin Xu, L. Zeng, 2018, Cell Death & Disease.

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma

Huizhong Li, Gang Wang, Kailin Xu, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia.

Kailin Xu, Xiao-yun Wang, Qing-yun Wu, 2022, International journal of biological macromolecules.

Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines

Kailin Xu, Zhen-Yu Li, Qing-yun Wu, 2022, Cellular Oncology.

The D14 and R138 ion pair is involved in dimeric arginine kinase activity, structural stability and folding.

Kailin Xu, L. Zeng, Zhen-Yu Li, 2014, International journal of biological macromolecules.

Roles of T875N somatic mutation in the activity, structural stability of JAK2 and the transformation of OCI-AML3 cells.

Kailin Xu, L. Zeng, Jiang Cao, 2019, International journal of biological macromolecules.

Roles of germline JAK2 activation mutation JAK2 V625F in the pathology of myeloproliferative neoplasms.

P. Zhou, Kailin Xu, L. Zeng, 2018, International journal of biological macromolecules.

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.

Yuekun Qi, K. Qi, Kailin Xu, 2023, Cytotherapy.

Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.

Yuekun Qi, R. Yao, K. Qi, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of K607 and E877 interaction is a key reason for JAK2 K607N mutation caused acute myeloid leukemia.

Kailin Xu, L. Zeng, Zhen-Yu Li, 2019, International journal of biological macromolecules.

Effects of JAK2 V556F mutation on the JAK2's activity, structural stability and the transformation of Ba/F3 cells.

P. Zhou, Kailin Xu, L. Zeng, 2018, International journal of biological macromolecules.

Effects of the I682F mutation on JAK2's activity, structure and stability.

Wei Li, P. Zhou, Kailin Xu, 2015, International journal of biological macromolecules.

CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia

P. Zhou, L. Zeng, Zhen-Yu Li, 2018, Cell Death & Disease.

Prognostic value of prelymphodepletion absolute lymphocyte counts in relapsed/refractory diffuse large B-cell lymphoma patients treated with chimeric antigen receptor T cells

Hai Cheng, Zhi-ling Yan, Zhenyu Li, 2023, Frontiers in Immunology.

A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells

J. Qiao, Hai Cheng, Zhi-ling Yan, 2023, Frontiers in Immunology.